162 related articles for article (PubMed ID: 6407305)
1. Double-blind randomized study of prophylactic trimethoprim/sulfamethoxazole in granulocytopenic patients with hematologic malignancies.
Gualtieri RJ; Donowitz GR; Kaiser DL; Hess CE; Sande MA
Am J Med; 1983 Jun; 74(6):934-40. PubMed ID: 6407305
[TBL] [Abstract][Full Text] [Related]
2. A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients.
Gurwith MJ; Brunton JL; Lank BA; Harding GK; Ronald AR
Am J Med; 1979 Feb; 66(2):248-56. PubMed ID: 371396
[TBL] [Abstract][Full Text] [Related]
3. Oral trimethoprim/sulfamethoxazole for prevention of bacterial infection during the induction phase of cancer chemotherapy in children.
Kovatch AL; Wald ER; Albo VC; Prin W; Orlando SJ; Wollman MR; Phebus CK; Shapiro ED
Pediatrics; 1985 Nov; 76(5):754-60. PubMed ID: 3903647
[TBL] [Abstract][Full Text] [Related]
4. Oral antibiotic prophylaxis in patients with cancer: a double-blind randomized placebo-controlled trial.
Pizzo PA; Robichaud KJ; Edwards BK; Schumaker C; Kramer BS; Johnson A
J Pediatr; 1983 Jan; 102(1):125-33. PubMed ID: 6336781
[TBL] [Abstract][Full Text] [Related]
5. Trimethoprim-sulfamethoxazole and trimethoprim alone for prophylaxis of infection in granulocytopenic patients.
Gurwith M; Truog K; Hinthorn D; Liu C
Rev Infect Dis; 1982; 4(2):593-601. PubMed ID: 6981175
[TBL] [Abstract][Full Text] [Related]
6. Empiric antimicrobial therapy in febrile granulocytopenic patients. Randomized prospective comparison of amikacin plus piperacillin with or without parenteral trimethoprim/sulphamethoxazole.
Menichetti F; Del Favero A; Guerciolini R; Tonato M; Aversa F; Roila F; Frongillo RF; Martelli MF; Davis S; Pauluzzi S
Infection; 1986; 14(6):261-7. PubMed ID: 3546144
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled trial comparing trimethoprim/sulfamethoxazole and trimethoprim for infection prophylaxis in hospitalized granulocytopenic patients.
Bow EJ; Louie TJ; Riben PD; McNaughton RD; Harding GK; Ronald AR
Am J Med; 1984 Feb; 76(2):223-33. PubMed ID: 6364804
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic trimethoprim-sulfamethoxazole during consolidation chemotherapy for acute leukemia: a controlled trial.
Weiser B; Lange M; Fialk MA; Singer C; Szatrowski TH; Armstrong D
Ann Intern Med; 1981 Oct; 95(4):436-8. PubMed ID: 7025721
[TBL] [Abstract][Full Text] [Related]
9. Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia.
Dekker AW; Rozenberg-Arska M; Sixma JJ; Verhoef J
Ann Intern Med; 1981 Nov; 95(5):555-9. PubMed ID: 6794406
[TBL] [Abstract][Full Text] [Related]
10. Reduction in mortality from gram-negative sepsis in neutropenic patients receiving trimethoprim/sulfamethoxazole therapy.
Riben PD; Louie TJ; Lank BA; Kornachuk E; Gurwith MJ; Harding GK; Ronald AR
Cancer; 1983 May; 51(9):1587-92. PubMed ID: 6339029
[TBL] [Abstract][Full Text] [Related]
11. Carbenicillin-trimethoprim/sulfamethoxazole versus carbenicillin-gentamicin as empiric therapy of infection in granulocytopenic patients. A prospective, randomized, double-blind study.
Stuart RK; Braine HG; Lietman PS; Saral R; Fuller DJ
Am J Med; 1980 Jun; 68(6):876-85. PubMed ID: 6992570
[TBL] [Abstract][Full Text] [Related]
12. Trimethoprim/sulfamethoxazole versus placebo: a double-blind comparison of infection prophylaxis in patients with small cell carcinoma of the lung.
de Jongh CA; Wade JC; Finley RS; Joshi JH; Aisner J; Wiernik PH; Schimpff SC
J Clin Oncol; 1983 May; 1(5):302-7. PubMed ID: 6321684
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic co-trimoxazole versus norfloxacin in neutropenic children--perspective randomized study.
Cruciani M; Concia E; Navarra A; Perversi L; Bonetti F; Aricò M; Nespoli L
Infection; 1989; 17(2):65-9. PubMed ID: 2654019
[TBL] [Abstract][Full Text] [Related]
14. Oral trimethoprim/sulfamethoxazole in attempt to prevent infection after induction chemotherapy for acute leukemia.
Henry SA; Armstrong D; Kempin S; Gee T; Arlin Z; Clarkson B
Am J Med; 1984 Oct; 77(4):663-6. PubMed ID: 6435446
[TBL] [Abstract][Full Text] [Related]
15. Norfloxacin for prevention of bacterial infections in granulocytopenic patients.
Winston DJ; Ho WG; Champlin RE; Karp J; Bartlett J; Finley RS; Joshi JH; Talbot G; Levitt L; Deresinski S
Am J Med; 1987 Jun; 82(6B):40-6. PubMed ID: 3037899
[TBL] [Abstract][Full Text] [Related]
16. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis.
Fox BC; Sollinger HW; Belzer FO; Maki DG
Am J Med; 1990 Sep; 89(3):255-74. PubMed ID: 2118307
[TBL] [Abstract][Full Text] [Related]
17. Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid.
Wade JC; de Jongh CA; Newman KA; Crowley J; Wiernik PH; Schimpff SC
J Infect Dis; 1983 Apr; 147(4):624-34. PubMed ID: 6842003
[TBL] [Abstract][Full Text] [Related]
18. Use of trimethoprim-sulfamethoxazole to prevent bacterial infections in children with acute lymphoblastic leukemia.
Goorin AM; Hershey BJ; Levin MJ; Siber GR; Gelber RD; Flynn K; Lew M; Beckett K; Blanding P; Sallan SE
Pediatr Infect Dis; 1985; 4(3):265-9. PubMed ID: 3889875
[TBL] [Abstract][Full Text] [Related]
19. [Prophylactic administration of antimicrobiological agents and reflection thereon--prevention of infections in hematologic diseases and malignancies].
Funada H
Nihon Rinsho; 1986 Apr; 44(4):925-9. PubMed ID: 3093732
[No Abstract] [Full Text] [Related]
20. Parenteral trimethoprim-sulfamethoxazole and carbenicillin as empiric therapy for neutropenic patients with cancer.
Braine HG; Stuart RK; Saral R; Lietman PS
Rev Infect Dis; 1982; 4(2):586-92. PubMed ID: 7051248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
